Trial Profile
Safety and pharmacokinetic study of pasireotide in healthy volunteers: a single centre, four-way crossover study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary) ; Moxifloxacin
- Indications Acromegaly; Gastrointestinal cancer; Gastrointestinal disorders; Gigantism; Liver cancer; Malignant melanoma; Meningioma; Merkel cell carcinoma; Neuroectodermal tumours; Pancreatic cancer; Pituitary ACTH hypersecretion; Pituitary cancer; Prostate cancer; Uveal melanoma
- Focus Adverse reactions; Pharmacokinetics
- 10 Dec 2015 New trial record